Connor, Clark & Lunn Investment Management (CC&L)
APLT

Connor, Clark & Lunn Investment Management (CC&L)’s Applied Therapeutics APLT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,304
Closed -$18.3K – 1354
2023
Q2 		$18.3K Buy
+14,304
New +$19K ﹤0.01% 1285
2022
Q2 		– Sell
-25,015
Closed -$53K – 1032
2022
Q1 		$53K Buy
+25,015
New +$67K ﹤0.01% 1001

Other funds holding APLT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s APLT Position: Q3 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Applied Therapeutics (APLT) in Q3 2023, closing a stake of 14,304 shares — an estimated $18.3K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in APLT in Q1 2022 and held it in 2 quarters. The position peaked at $53K in Q1 2022. 55 funds tracked by Wall St. Rank hold APLT as of Q3 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Applied Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 14,304 Applied Therapeutics shares in Q3 2023, an estimated $18.3K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Applied Therapeutics in Q1 2022 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Applied Therapeutics position peaked at $53K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2023, filed 13 Nov 2023.